Do ATP and NO interact in the CNS?

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Extracellular adenosine triphosphate (ATP) and nitric oxide (NO) function as key signaling molecules in the central nervous system (CNS).
• Purinergic signaling involves ionotropic (P2XR) and metabotropic (P2YR) receptors, with P2XRs critical for brain plasticity and CNS disease pathogenesis.
• Nitric oxide (NO) lacks specific receptors, with its actions dependent on nitric oxide synthase (NOS) isoforms, influencing diverse physiological and pathological functions.

Purpose of the Study:

• To review the interplay between purinergic and nitrergic systems, with a focus on their interactions within the CNS.
• To consolidate current knowledge on the physiological and pathological relevance of ATP and NO signaling in the brain.
• To explore the potential of targeting ATP/NO cross-talk for developing combined pharmacological agents.

Main Methods:

• Literature review of existing studies on purinergic and nitrergic signaling in the CNS.
• Analysis of experimental evidence detailing the interactions between ATP and NO pathways.
• Synthesis of information regarding the roles of ATP and NO in CNS physiological and pathological processes.

Main Results:

• Both ATP and NO modulate various tissues, including the immune, brain, and vascular systems.
• Direct interactions between purinergic and nitrergic mechanisms are documented both outside and within the CNS.
• Emerging evidence highlights the physiological and pathological significance of direct ATP and NO interactions in the CNS.

Conclusions:

• The cross-talk between purinergic and nitrergic systems is integral to CNS function and dysfunction.
• Understanding ATP/NO interactions provides a basis for developing novel therapeutic strategies.
• Combined pharmacological approaches targeting both ATP and NO signaling hold promise for treating CNS disorders.